FDA
-
-
-
-
-
-
-
Elutia reports Q4 revenue up 16%, eliminates $26.9M debt
-
-
-
-
-
-
-
Elutia publishes clinical data on biologic envelopes for cardiac devices
-
-
-
-
-
-
-
Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption
-
-
-
-
-
-
-
Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice
-
-
-
-
-
-
-
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
-
-
-
-
-
-
-
SWK Holdings (SWKH) Provides Portfolio Update
-
-
-
-
-
-
-
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
-
322,879 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

